authors
- Ghezelayagh, Talayeh S
- Neubauer, Nikki L
- Dai, James Y
- Tanyi, Janos L
- Liao, John B
- Wu, Emily S
- Emma Barber, MD, MS
- Dao, Minh D
- Zsiros, Emese
- Urban, Renata R
- Gray, Heidi J
- Goff, Barbara A
- Shah, Chirag A
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study.
- Overview
- Research
- Identity
- Additional Document Info
- View All